Cargando…

Development of global consensus sequence of HCV glycoproteins involved in viral entry

BACKGROUND: HCV affects >170 million people worldwide and is a leading cause of liver diseases such as hepatocellular carcinoma. Each year, Pakistan reports hundreds of cases and now it has become a serious health issue. HCV has two transmembrane glycoproteins (E1 and E2) that are involved in vir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Idrees, Sobia, Ashfaq, Usman A, Idrees, Natasha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639888/ https://www.ncbi.nlm.nih.gov/pubmed/23575038 http://dx.doi.org/10.1186/1742-4682-10-24

Ejemplares similares

Global Consensus Sequence Development and Analysis of Dengue NS3 Conserved Domains
por: Ayub, Ambreen, et al.
Publicado: (2013)

HCV Envelope protein 2 sequence comparison of Pakistani isolate and In-silico prediction of conserved epitopes for vaccine development
por: Idrees, Sobia, et al.
Publicado: (2013)

Structural analysis and epitope prediction of HCV E1 protein isolated in Pakistan: an in-silico approach
por: Idrees, Sobia, et al.
Publicado: (2013)

Computer aided screening of Accacia nilotica phytochemicals against HCV NS3/4a
por: Khan, Mahim, et al.
Publicado: (2013)

A brief review on dengue molecular virology, diagnosis, treatment and prevalence in Pakistan
por: Idrees, Sobia, et al.
Publicado: (2012)

Lysosomotropic agents as HCV entry inhibitors
por: Ashfaq, Usman A, et al.
Publicado: (2011)

Molecular screening of phytochemicals from Amelanchier Alnifolia against HCV NS3 protease/helicase using computational docking techniques
por: Khan, Mahim, et al.
Publicado: (2013)

Determination of HCV genotypes and viral loads in chronic HCV infected patients of Hazara Pakistan
por: Ali, Amjad, et al.
Publicado: (2011)

Generation of fluorescent HCV pseudoparticles to study early viral entry events- involvement of Rab1a in HCV entry
por: Bhattacharjee, Chayan, et al.
Publicado: (2022)

P2X4 receptors mediate induction of antioxidants, fibrogenic cytokines and ECM transcripts; in presence of replicating HCV in in vitro setting: An insight into role of P2X4 in fibrosis
por: Manzoor, Sobia, et al.
Publicado: (2022)

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
por: Ashfaq, Usman A, et al.
Publicado: (2011)

The first complete genome sequence of HCV-1a from Pakistan and a phylogenetic analysis with complete genomes from the rest of the world
por: Hussain, Abrar, et al.
Publicado: (2013)

Promiscuous prediction and conservancy analysis of CTL binding epitopes of HCV 3a viral proteome from Punjab Pakistan: an In Silico Approach
por: Shehzadi, Abida, et al.
Publicado: (2011)

Targeting HCV Entry For Development of Therapeutics
por: Wong-Staal, Flossie, et al.
Publicado: (2010)

Development of Global Consensus Sequence and Analysis of Highly Conserved Domains of the HCV NS5B Prote in
por: Waheed, Yasir, et al.
Publicado: (2012)

De Novo modeling of Envelope 2 protein of HCV isolated from Pakistani patient and epitopes prediction for vaccine development
por: Afzal, Samia, et al.
Publicado: (2014)

The Role of Phlebovirus Glycoproteins in Viral Entry, Assembly and Release
por: Spiegel, Martin, et al.
Publicado: (2016)

Response to combination therapy of HCV 3a infected Pakistani patients and the role of NS5A protein
por: Ali, Ijaz, et al.
Publicado: (2011)

Expression of core antigen of HCV genotype 3a and its evaluation as screening agent for HCV infection in Pakistan
por: Yousaf, Muhammad Z, et al.
Publicado: (2011)

The Secret Life of Viral Entry Glycoproteins: Moonlighting in Immune Evasion
por: Cook, Jonathan D., et al.
Publicado: (2013)

Expression of Ebolavirus glycoprotein on the target cells enhances viral entry
por: Manicassamy, Balaji, et al.
Publicado: (2009)

Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry
por: Wang, Jizhen, et al.
Publicado: (2011)

Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a
por: Manzoor, Sobia, et al.
Publicado: (2011)

HIV-1 Diversity in the Envelope Glycoproteins: Implications for Viral Entry Inhibition
por: Araújo, Leonardo Augusto Luvison, et al.
Publicado: (2013)

Computer Aided Screening of Phytochemicals from Garcinia against the Dengue NS2B/NS3 Protease
por: Qamar, Tahir ul, et al.
Publicado: (2014)

Computational Prediction and Analysis of Envelop Glycoprotein Epitopes of DENV-2 and DENV-3 Pakistani Isolates: A First Step towards Dengue Vaccine Development
por: Amat-ur-Rasool, Hafsa, et al.
Publicado: (2015)

HCV Glycoprotein Structure and Implications for B-Cell Vaccine Development
por: Ströh, Luisa J., et al.
Publicado: (2020)

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV
por: Jahan, Shah, et al.
Publicado: (2011)

SLiM-Enrich: computational assessment of protein–protein interaction data as a source of domain-motif interactions
por: Idrees, Sobia, et al.
Publicado: (2018)

Correction: SLiMEnrich: computational assessment of protein–protein interaction data as a source of domain-motif interactions
por: Idrees, Sobia, et al.
Publicado: (2018)

A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner
por: Lee, Myungeun, et al.
Publicado: (2017)

HCV entry receptors as potential targets for siRNA-based inhibition of HCV
por: Jahan, Shah, et al.
Publicado: (2011)

Entry inhibitors: New advances in HCV treatment
por: Qian, Xi-Jing, et al.
Publicado: (2016)

An Immunoinformatics Approach to Design a Potent Multi-Epitope Vaccine against Asia-1 Genotype of Crimean–Congo Haemorrhagic Fever Virus Using the Structural Glycoproteins as a Target
por: Shah, Syed Zawar, et al.
Publicado: (2022)

Phylogenetic and 2D/3D Analysis of HCV 1a NS4A Gene/Protein in Pakistani Isolates
por: Hussain, Abrar, et al.
Publicado: (2015)

Occurrence of genetic modifications in core, 5′UTR and NS5b of HCV associated with viral response to treatment
por: Kanwal, Sobia, et al.
Publicado: (2014)

Hepatitis C Virus (HCV) Envelope Glycoproteins E1 and E2 Contain Reduced Cysteine Residues Essential for Virus Entry
por: Fraser, Johanna, et al.
Publicado: (2011)

A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry
por: Fels, J. Maximilian, et al.
Publicado: (2019)

How different viruses perturb host cellular machinery via short linear motifs
por: Idrees, Sobia, et al.
Publicado: (2023)

Syndecan 4 Is Involved in Mediating HCV Entry through Interaction with Lipoviral Particle-Associated Apolipoprotein E
por: Lefèvre, Mathieu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a7knj8h6cjm0q8kklu2prj47dc